{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:26Z","timestamp":1761749006016,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004770","name":"university of parma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04476-y","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:15:30Z","timestamp":1761747330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two journeys, one diagnosis: exploring the clinical outcomes of twins with congenital\u00a0myopathy"],"prefix":"10.1186","volume":"25","author":[{"given":"M. C.","family":"Pera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pisan\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gnazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Percesepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"4476_CR1","doi-asserted-by":"publisher","unstructured":"Slavotinek A. Genetic and genomic results and management. Genomics in the clinic. Elsevier; 2024. pp. 93\u2013110. https:\/\/doi.org\/10.1016\/B978-0-12-816478-5.00007-8.","DOI":"10.1016\/B978-0-12-816478-5.00007-8"},{"issue":"5","key":"4476_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","volume":"15","author":"TV McCarthy","year":"2000","unstructured":"McCarthy TV, Quane KA, Lynch PJ. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat. 2000;15(5):410\u20137. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(200005)15:5%3C410::AID-HUMU2%3E3.0.CO;2-D.","journal-title":"Hum Mutat"},{"issue":"5","key":"4476_CR3","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1529\/biophysj.104.048447","volume":"87","author":"RT Dirksen","year":"2004","unstructured":"Dirksen RT, Avila G. Distinct effects on Ca2\u2009+\u2009Handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys J. 2004;87(5):3193\u2013204. https:\/\/doi.org\/10.1529\/biophysj.104.048447.","journal-title":"Biophys J"},{"issue":"3","key":"4476_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","volume":"8","author":"S Treves","year":"2008","unstructured":"Treves S, Jungbluth H, Muntoni F, Zorzato F. Congenital muscle disorders with cores: the Ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol. 2008;8(3):319\u201326. https:\/\/doi.org\/10.1016\/j.coph.2008.01.005.","journal-title":"Curr Opin Pharmacol"},{"issue":"42","key":"4476_CR5","doi-asserted-by":"publisher","first-page":"43838","DOI":"10.1074\/jbc.M403612200","volume":"279","author":"S Ducreux","year":"2004","unstructured":"Ducreux S, Zorzato F, M\u00fcller C, Sewry C, Muntoni F, Quinlivan R, Restagno G, Girard T, Treves S. Effect of Ryanodine receptor mutations on Interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant Hyperthermia-Susceptible individuals and patients affected by central core disease. J Biol Chem. 2004;279(42):43838\u201346. https:\/\/doi.org\/10.1074\/jbc.M403612200.","journal-title":"J Biol Chem"},{"issue":"4","key":"4476_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JND-150073","volume":"2","author":"M Cacheux","year":"2015","unstructured":"Cacheux M, Blum A, S\u00e9bastien M, Wozny AS, Brocard J, Mamchaoui K, Mouly V, Roux-Buisson N, Rendu J, Monnier N, Krivosic R, Allen P, Lacour A, Lunardi J, Faur\u00e9 J, Marty I. Functional characterization of a central core disease RyR1 mutation (p.Y4864H) associated with quantitative defect in RyR1 protein. J Neuromuscul Dis. 2015;2(4):421\u201332. https:\/\/doi.org\/10.3233\/JND-150073.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"4476_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1124\/mol.117.111468","volume":"94","author":"T Murayama","year":"2018","unstructured":"Murayama T, Kurebayashi N, Ishigami-Yuasa M, Mori S, Suzuki Y, Akima R, Ogawa H, Suzuki J, Kanemaru K, Oyamada H, Kiuchi Y, Iino M, Kagechika H, Sakurai T. Efficient High-Throughput screening by Endoplasmic reticulum Ca2\u2009+\u2009Measurement to identify inhibitors of Ryanodine receptor Ca2+-Release channels. Mol Pharmacol. 2018;94(1):722\u201330. https:\/\/doi.org\/10.1124\/mol.117.111468.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"4476_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1152\/physrev.1997.77.3.699","volume":"77","author":"C Franzini-Armstrong","year":"1997","unstructured":"Franzini-Armstrong C, Protasi F. Ryanodine receptors of striated muscles: A complex channel capable of multiple interactions. Physiol Rev. 1997;77(3):699\u2013729. https:\/\/doi.org\/10.1152\/physrev.1997.77.3.699.","journal-title":"Physiol Rev"},{"issue":"4","key":"4476_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s13311-018-00677-1","volume":"15","author":"TA Lawal","year":"2018","unstructured":"Lawal TA, Todd JJ, Meilleur KG. Ryanodine receptor 1-Related myopathies: diagnostic and therapeutic approaches. Neurotherapeutics. 2018;15(4):885\u201399. https:\/\/doi.org\/10.1007\/s13311-018-00677-1.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"4476_CR10","doi-asserted-by":"publisher","first-page":"e202313486","DOI":"10.1085\/jgp.202313486","volume":"156","author":"S Benucci","year":"2024","unstructured":"Benucci S, Ruiz A, Franchini M, Ruggiero L, Zoppi D, Sitsapesan R, Lindsay C, Pelczar P, Pietrangelo L, Protasi F, Treves S, Zorzato FA, Novel. Patient-Derived RyR1 mutation impairs muscle function and calcium homeostasis in mice. J Gen Physiol. 2024;156(4):e202313486. https:\/\/doi.org\/10.1085\/jgp.202313486.","journal-title":"J Gen Physiol"},{"issue":"2","key":"4476_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10974-020-09575-6","volume":"42","author":"H Ogawa","year":"2021","unstructured":"Ogawa H, Kurebayashi N, Yamazawa T, Murayama T. Regulatory mechanisms of Ryanodine Receptor\/Ca2\u2009+\u2009Release channel revealed by recent advancements in structural studies. J Muscle Res Cell Motil. 2021;42(2):291\u2013304. https:\/\/doi.org\/10.1007\/s10974-020-09575-6.","journal-title":"J Muscle Res Cell Motil"},{"issue":"3","key":"4476_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.32641\/andespediatr.v94i3.4097","volume":"94","author":"A Mosca-Hayler","year":"2023","unstructured":"Mosca-Hayler A, L\u00f3pez-Schmidt D, Cigarroa I, Curotto-Noce R, Baja\u00f1a-Rugel G. Deformidades Craneales posicionales En lactantes prematuros y Asociaci\u00f3n Con indicadores de Salud. Andes Pediatr. 2023;94(3):361. https:\/\/doi.org\/10.32641\/andespediatr.v94i3.4097.","journal-title":"Andes Pediatr"},{"issue":"1","key":"4476_CR13","doi-asserted-by":"publisher","first-page":"19072","DOI":"10.1038\/s41598-019-55604-x","volume":"9","author":"SK Yum","year":"2019","unstructured":"Yum SK, Im SA, Seo YM, Sung IK. Enlarged subarachnoid space on cranial ultrasound in preterm infants: neurodevelopmental implication. Sci Rep. 2019;9(1):19072. https:\/\/doi.org\/10.1038\/s41598-019-55604-x.","journal-title":"Sci Rep"},{"issue":"10","key":"4476_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","volume":"132","author":"DN Cooper","year":"2013","unstructured":"Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an Understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132(10):1077\u2013130. https:\/\/doi.org\/10.1007\/s00439-013-1331-2.","journal-title":"Hum Genet"},{"issue":"6","key":"4476_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.17116\/jnevro2022122061118","volume":"122","author":"SV Kotov","year":"2022","unstructured":"Kotov SV, Sidorova OP, Borodataya EV. A pilot study of idebenone in the treatment of patients with hereditary myopathies. Zhurnal Nevrol Psikhiatrii Im SS Korsakova. 2022;122(6):118. https:\/\/doi.org\/10.17116\/jnevro2022122061118.","journal-title":"Zhurnal Nevrol Psikhiatrii Im SS Korsakova"},{"issue":"3","key":"4476_CR16","doi-asserted-by":"publisher","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","volume":"6","author":"RH Haefeli","year":"2011","unstructured":"Haefeli RH, Erb M, Gemperli AC, Robay D, Courdier Fruh I, Anklin C, Dallmann R, Gueven N. NQO1-Dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS ONE. 2011;6(3):e17963. https:\/\/doi.org\/10.1371\/journal.pone.0017963.","journal-title":"PLoS ONE"},{"issue":"6","key":"4476_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.nmd.2011.02.016","volume":"21","author":"GM Buyse","year":"2011","unstructured":"Buyse GM, Goemans N, Van Den Hauwe M, Thijs D, De Groot IJM, Schara U, Ceulemans B, Meier T, Mertens L. Idebenone as a Novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 Month, Double-Blind, randomized Placebo-Controlled trial. Neuromuscul Disord. 2011;21(6):396\u2013405. https:\/\/doi.org\/10.1016\/j.nmd.2011.02.016.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"4476_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3233\/JND-170245","volume":"4","author":"OH Mayer","year":"2017","unstructured":"Mayer OH, Leinonen M, Rummey C, Meier T, Buyse GM, for the DELOS Study Group. Efficacy of idebenone to preserve respiratory function above clinically meaningful thresholds for forced vital capacity (FVC) in patients with Duchenne muscular dystrophy. J Neuromuscul Dis. 2017;4(3):189\u201398. https:\/\/doi.org\/10.3233\/JND-170245.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"4476_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/iep.12463","volume":"104","author":"AH Valduga","year":"2023","unstructured":"Valduga AH, Mizobuti DS, Moraes FDSR, M\u00e2ncio RD, Moraes LHR, Hermes TDA, Macedo AB, Minatel E. Protection of dystrophic muscle cells using idebenone correlates with the interplay between Calcium, oxidative stress and inflammation. Int J Exp Pathol. 2023;104(1):4\u201312. https:\/\/doi.org\/10.1111\/iep.12463.","journal-title":"Int J Exp Pathol"},{"issue":"9","key":"4476_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/hmg\/ddaf021","volume":"34","author":"A Ruiz","year":"2025","unstructured":"Ruiz A, Noreen F, Meier H, Buczak K, Zorzato F, Treves S. 5-Aza-2-Deoxycytidine improves skeletal muscle function in a mouse model for recessive RYR1 -Related congenital myopathy. Hum Mol Genet. 2025;34(9):790\u2013805. https:\/\/doi.org\/10.1093\/hmg\/ddaf021.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04476-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04476-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04476-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:15:31Z","timestamp":1761747331000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04476-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4476"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04476-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by appropriate regulatory and ethical authorities at the ethics committee of University Hospital of Parma (protocol 213\/2025).Written informed consent was obtained from the parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained written informed consent from the parents for personal or clinical details in this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"444"}}